The molecular weight of methotrexate (MTX) makes cutaneous penetration difficult. Oxygen flow could enhance the skin permeation of MTX diluted in the proprietary LP3 carrier system. This pilot study aims to assess the efficacy, safety, and tolerance of oxygen flow-assisted LP3-MTX3% for treating superficial skin cancers.

Translate to: / Translate to: / Traduire vers:

Treating superficial skin cancers

Exploratory Assessment of Oxygen Flow - Assisted Cutaneous Administration of Methotrexate for Superficial Basal Cell Carcinoma, Mycosis Fungoides, and Extramammary Paget Disease Treating superficial skin cancers

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this website and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies. Please note that if you reject your application, it is possible that not all functions of the site will be available.